BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Issa R, Williams E, Trim N, Kendall T, Arthur MJ, Reichen J, Benyon RC, Iredale JP. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut. 2001;48:548-557. [PMID: 11247901 DOI: 10.1136/gut.48.4.548] [Cited by in Crossref: 223] [Cited by in F6Publishing: 209] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 Lee HS, Choi J, Son T, Wee HJ, Bae SJ, Seo JH, Park JH, Ryu SH, Lee D, Jang MK, Yu E, Chung YH, Kim KW. Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution. Exp Mol Med 2018;50:1-13. [PMID: 29700280 DOI: 10.1038/s12276-018-0074-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ruehl M, Erben U, Kim K, Freise C, Dagdelen T, Eisele S, Trowitzsch-Kienast W, Zeitz M, Jia J, Stickel F. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern. J Nutr Biochem. 2009;20:597-606. [PMID: 18824344 DOI: 10.1016/j.jnutbio.2008.06.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
3 Andrade CM, Wink MR, Margis R, Borojevic R, Battastini AM, Guma FC. Activity and expression of ecto-nucleotide pyrophosphate/phosphodiesterases in a hepatic stellate cell line. Mol Cell Biochem 2009;325:179-85. [PMID: 19194664 DOI: 10.1007/s11010-009-0032-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
4 Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol 2021;27:413-24. [PMID: 33317250 DOI: 10.3350/cmh.2020.0187] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Davaille J, Li L, Mallat A, Lotersztajn S. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem. 2002;277:37323-37330. [PMID: 12138095 DOI: 10.1074/jbc.m202798200] [Cited by in Crossref: 73] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
6 Senoo H, Yoshikawa K, Morii M, Miura M, Imai K, Mezaki Y. Hepatic stellate cell (vitamin A-storing cell) and its relative--past, present and future. Cell Biol Int. 2010;34:1247-1272. [PMID: 21067523 DOI: 10.1042/cbi20100321] [Cited by in Crossref: 109] [Cited by in F6Publishing: 35] [Article Influence: 10.9] [Reference Citation Analysis]
7 Bennett RG, Kharbanda KK, Tuma DJ. Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem Pharmacol. 2003;66:867-874. [PMID: 12948868 DOI: 10.1016/s0006-2952(03)00403-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
8 Vainshtein JM, Kabarriti R, Mehta KJ, Roy-Chowdhury J, Guha C. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2014;89:786-803. [PMID: 24969793 DOI: 10.1016/j.ijrobp.2014.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
9 Elrick LJ, Leel V, Blaylock MG, Duncan L, Drever MR, Strachan G, Charlton KA, Koruth M, Porter AJ, Wright MC. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics. J Hepatol. 2005;42:888-896. [PMID: 15885360 DOI: 10.1016/j.jhep.2005.01.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
10 Zhang BB, Cai WM, Weng HL, Hu ZR, Lu J, Zheng M, Liu RH. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis. World J Gastroenterol 2003;9:2490-6. [PMID: 14606082 DOI: 10.3748/wjg.v9.i11.2490] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
11 El Taghdouini A, Najimi M, Sancho-Bru P, Sokal E, van Grunsven LA. In vitro reversion of activated primary human hepatic stellate cells. Fibrogenesis Tissue Repair 2015;8:14. [PMID: 26251672 DOI: 10.1186/s13069-015-0031-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
12 Jiao J, Sastre D, Fiel MI, Lee UE, Ghiassi-Nejad Z, Ginhoux F, Vivier E, Friedman SL, Merad M, Aloman C. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology. 2012;55:244-255. [PMID: 21898476 DOI: 10.1002/hep.24621] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 10.4] [Reference Citation Analysis]
13 de Oliveira da Silva B, Ramos LF, Moraes KCM. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int 2017;41:946-59. [PMID: 28498509 DOI: 10.1002/cbin.10790] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
14 Geng XX, Yang Q, Xie RJ, Luo XH, Han B, Ma L, Li CX, Cheng ML. In vivo effects of Chinese herbal recipe, Danshaohuaxian, on apoptosis and proliferation of hepatic stellate cells in hepatic fibrotic rats. World J Gastroenterol. 2005;11:561-566. [PMID: 15641146 DOI: 10.3748/wjg.v11.i4.561] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
15 Pavithra PS, Mehta A, Verma RS. Induction of apoptosis by essential oil from P. missionis in skin epidermoid cancer cells. Phytomedicine 2018;50:184-95. [PMID: 30466977 DOI: 10.1016/j.phymed.2017.11.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
16 Leung TM, Wang X, Kitamura N, Fiel MI, Nieto N. Osteopontin delays resolution of liver fibrosis. Lab Invest. 2013;93:1082-1089. [PMID: 23999249 DOI: 10.1038/labinvest.2013.104] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
17 Louka ML, Ramzy MM. Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis. Gene 2016;579:29-33. [PMID: 26721462 DOI: 10.1016/j.gene.2015.12.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
18 Dekel R, Zvibel I, Brill S, Brazovsky E, Halpern Z, Oren R. Gliotoxin ameliorates development of fibrosis and cirrhosis ina thioacetamide rat model. Dig Dis Sci. 2003;48:1642-1647. [PMID: 12924662 DOI: 10.1023/A:1024792529601] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
19 Tag CG, Weiskirchen S, Hittatiya K, Tacke F, Tolba RH, Weiskirchen R. Induction of experimental obstructive cholestasis in mice. Lab Anim. 2015;49:70-80. [PMID: 25835740 DOI: 10.1177/0023677214567748] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
20 Abdalla AF, Zalata KR, Ismail AF, Shiha G, Attiya M, Abo-Alyazeed A. Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods. Fibrogenesis Tissue Repair. 2009;2:2. [PMID: 19341455 DOI: 10.1186/1755-1536-2-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
21 Lin HJ, Chen JY, Lin CF, Kao ST, Cheng JC, Chen HL, Chen CM. Hepatoprotective effects of Yi Guan Jian, an herbal medicine, in rats with dimethylnitrosamine-induced liver fibrosis. J Ethnopharmacol 2011;134:953-60. [PMID: 21333722 DOI: 10.1016/j.jep.2011.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
22 Luna J, Masamunt MC, Lawrance IC, Sans M. Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention. Am J Physiol Gastrointest Liver Physiol 2011;300:G703-8. [PMID: 21233275 DOI: 10.1152/ajpgi.00504.2010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
23 Takahashi Y, Fukusato T. Animal Models of Liver Diseases. Animal Models for the Study of Human Disease. Elsevier; 2017. pp. 313-39. [DOI: 10.1016/b978-0-12-809468-6.00013-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Pan Q, Li DG, Lu HM, Lu LY, Wang YQ, Xu QF. Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World J Gastroenterol 2004;10:1015-8. [PMID: 15052685 DOI: 10.3748/wjg.v10.i7.1015] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
25 Maia JM, Maranhão Hde S, Sena LV, Rocha LR, Medeiros IA, Ramos AM. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission. Eur J Gastroenterol Hepatol 2010;22:264-9. [PMID: 20009940 DOI: 10.1097/MEG.0b013e328326cab6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Cordero-Espinoza L, Huch M. The balancing act of the liver: tissue regeneration versus fibrosis. J Clin Invest 2018;128:85-96. [PMID: 29293095 DOI: 10.1172/JCI93562] [Cited by in Crossref: 77] [Cited by in F6Publishing: 45] [Article Influence: 25.7] [Reference Citation Analysis]
27 Ramachandran P, Iredale JP. Liver fibrosis: a bidirectional model of fibrogenesis and resolution. QJM. 2012;105:813-817. [PMID: 22647759 DOI: 10.1093/qjmed/hcs069] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
28 Zhang XL, Liu L, Jiang HQ. Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation. World J Gastroenterol 2002;8:515-9. [PMID: 12046082 DOI: 10.3748/wjg.v8.i3.515] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
29 Rockey DC. Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis 2008;12:939-62, xi. [PMID: 18984475 DOI: 10.1016/j.cld.2008.07.011] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 9.3] [Reference Citation Analysis]
30 Lee JS, Kim JH. [The role of activated hepatic stellate cells in liver fibrosis, portal hypertension and cancer angiogenesis]. Korean J Hepatol 2007;13:309-19. [PMID: 17898548 DOI: 10.3350/kjhep.2007.13.3.309] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
31 Murphy F, Waung J, Collins J, Arthur MJ, Nagase H, Mann D, Benyon RC, Iredale JP. N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1. Comp Hepatol. 2004;3 Suppl 1:S8. [PMID: 14960160 DOI: 10.1186/1476-5926-2-s1-s8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
32 Shi H, Dong L, Bai Y, Zhao J, Zhang Y, Zhang L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol. 2009;623:119-124. [PMID: 19786014 DOI: 10.1016/j.ejphar.2009.09.026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
33 Xie J, Zeng Q, Wang M, Ou X, Ma Y, Cheng A, Zhao XX, Liu M, Zhu D, Chen S, Jia R, Yang Q, Wu Y, Zhang S, Liu Y, Yu Y, Zhang L, Chen X. Transcriptomic Characterization of a Chicken Embryo Model Infected With Duck Hepatitis A Virus Type 1. Front Immunol 2018;9:1845. [PMID: 30197639 DOI: 10.3389/fimmu.2018.01845] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
34 Kim JY, Kim KM, Nan JX, Zhao YZ, Park PH, Lee SJ, Sohn DH. Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells. Pharmacol Toxicol. 2003;92:195-200. [PMID: 12753423 DOI: 10.1034/j.1600-0773.2003.920410.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
35 Lupher ML, Gallatin WM. Regulation of Fibrosis by the Immune System. Elsevier; 2006. pp. 245-88. [DOI: 10.1016/s0065-2776(05)89006-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
36 Kuo LM, Kuo CY, Lin CY, Hung MF, Shen JJ, Hwang TL. Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules 2014;19:3327-44. [PMID: 24647034 DOI: 10.3390/molecules19033327] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 9.7] [Reference Citation Analysis]
37 Huang Y, Deng X, Liang J. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis. Exp Cell Res. 2017;352:420-426. [PMID: 28238836 DOI: 10.1016/j.yexcr.2017.02.038] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 12.5] [Reference Citation Analysis]
38 Liu C, Sun M, Yan X, Han L, Zhang Y, Liu C, El-Nezami H, Liu P. Inhibition of hepatic stellate cell activation following Yinchenhao decoction administration to dimethylnitrosamine-treated rats. Hepatol Res. 2008;38:919-929. [PMID: 18371158 DOI: 10.1111/j.1872-034x.2008.00346.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
39 Oakley F, Trim N, Constandinou CM, Ye W, Gray AM, Frantz G, Hillan K, Kendall T, Benyon RC, Mann DA, Iredale JP. Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol. 2003;163:1849-1858. [PMID: 14578185 DOI: 10.1016/s0002-9440(10)63544-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
40 Nowatzky J, Knorr A, Hirth-Dietrich C, Siegling A, Volk HD, Limmer A, Knolle P, Weber O. Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis. Hepatol Res 2013;43:535-46. [PMID: 22971208 DOI: 10.1111/j.1872-034X.2012.01086.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
41 Malik R, Habib M, Tootle R, Hodgson H. Exogenous Thyroid Hormone Induces Liver Enlargement, Whilst Maintaining Regenerative Potential-A Study Relevant to Donor Preconditioning. Am J Transplant 2005;5:1801-7. [DOI: 10.1111/j.1600-6143.2005.00949.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
42 Czaja AJ. Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther. 2014;39:385-406. [PMID: 24387318 DOI: 10.1111/apt.12592] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
43 Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803-816. [PMID: 19090740 DOI: 10.1586/17474124.2.6.803] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
44 Park E, Zhao Y, Kim Y, Sohn DH. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. European Journal of Pharmacology 2007;559:115-23. [DOI: 10.1016/j.ejphar.2007.01.024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
45 Bannert K, Kuhla A, Abshagen K, Vollmar B. Anti-apoptotic therapeutic approaches in liver diseases: do they really make sense? Apoptosis 2014;19:1243-53. [PMID: 24872082 DOI: 10.1007/s10495-014-1004-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Montano-Loza AJ, Thandassery RB, Czaja AJ. Targeting Hepatic Fibrosis in Autoimmune Hepatitis. Dig Dis Sci. 2016;61:3118-3139. [PMID: 27435327 DOI: 10.1007/s10620-016-4254-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
47 Mehal W, Imaeda A. Cell death and fibrogenesis. Semin Liver Dis. 2010;30:226-231. [PMID: 20665375 DOI: 10.1055/s-0030-1255352] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
48 Horowitz JC, Thannickal VJ. Mechanisms for the Resolution of Organ Fibrosis. Physiology (Bethesda) 2019;34:43-55. [PMID: 30540232 DOI: 10.1152/physiol.00033.2018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
49 Liu XJ, Yang L, Wu HB, Qiang O, Huang MH, Wang YP. Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. World J Gastroenterol 2002;8:734-8. [PMID: 12174388 DOI: 10.3748/wjg.v8.i4.734] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
50 Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol. 2004;40:860-867. [PMID: 15094237 DOI: 10.1016/j.jhep.2004.03.007] [Cited by in Crossref: 157] [Cited by in F6Publishing: 136] [Article Influence: 9.2] [Reference Citation Analysis]
51 Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology. 2004;39:1631-1638. [PMID: 15185304 DOI: 10.1002/hep.20235] [Cited by in Crossref: 92] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
52 Toriyabe N, Sakurai Y, Kato A, Yamamoto S, Tange K, Nakai Y, Akita H, Harahsima H. The Delivery of Small Interfering RNA to Hepatic Stellate Cells Using a Lipid Nanoparticle Composed of a Vitamin A-Scaffold Lipid-Like Material. J Pharm Sci 2017;106:2046-52. [PMID: 28456722 DOI: 10.1016/j.xphs.2017.04.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
53 Andrade CM, Roesch GC, Wink MR, Guimarães EL, Souza LF, Jardim FR, Guaragna RM, Bernard EA, Margis R, Borojevic R, Battastini AM, Guma FC. Activity and expression of ecto-5'-nucleotidase/CD73 are increased during phenotype conversion of a hepatic stellate cell line. Life Sci 2008;82:21-9. [PMID: 18037449 DOI: 10.1016/j.lfs.2007.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
54 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1634/stemcells.2007-0252"> [DOI: 10.1111/j.1582-4934.2006.tb00292.x] [Reference Citation Analysis]
55 Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005;10:927-939. [PMID: 16151628 DOI: 10.1007/s10495-005-1055-4] [Cited by in Crossref: 294] [Cited by in F6Publishing: 275] [Article Influence: 19.6] [Reference Citation Analysis]
56 Bridle KR, Li L, O'Neill R, Britton RS, Bacon BR. Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells. J Lab Clin Med 2006;147:234-41. [PMID: 16697771 DOI: 10.1016/j.lab.2005.12.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
57 Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, Jonsson JR, Powell EE. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002;51:89-94. [PMID: 12077098 DOI: 10.1136/gut.51.1.89] [Cited by in Crossref: 195] [Cited by in F6Publishing: 179] [Article Influence: 10.3] [Reference Citation Analysis]
58 Saxena NK, Titus MA, Ding X, Floyd J, Srinivasan S, Sitaraman SV, Anania FA. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J. 2004;18:1612-1614. [PMID: 15319373 DOI: 10.1096/fj.04-1847fje] [Cited by in Crossref: 149] [Cited by in F6Publishing: 149] [Article Influence: 8.8] [Reference Citation Analysis]
59 Kikuchi A, Singh S, Poddar M, Nakao T, Schmidt HM, Gayden JD, Sato T, Arteel GE, Monga SP. Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-α Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury. Am J Pathol 2020;190:2080-94. [PMID: 32615075 DOI: 10.1016/j.ajpath.2020.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zhao Z, Lin CY, Cheng K. siRNA- and miRNA-based therapeutics for liver fibrosis. Transl Res 2019;214:17-29. [PMID: 31476281 DOI: 10.1016/j.trsl.2019.07.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
61 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1016/s0140-6736(08)60383-9] [Cited by in Crossref: 1212] [Cited by in F6Publishing: 502] [Article Influence: 93.2] [Reference Citation Analysis]
62 Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. The Lancet Gastroenterology & Hepatology 2016;1:328-40. [DOI: 10.1016/s2468-1253(16)30110-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
63 Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells 2020;9:E929. [PMID: 32290100 DOI: 10.3390/cells9040929] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
64 Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Ann Hepatol. 2009;8:283-291. [PMID: 20009126 DOI: 10.1016/s1665-2681(19)31740-5] [Cited by in Crossref: 69] [Article Influence: 6.3] [Reference Citation Analysis]
65 Motoyama H, Tamori A, Kubo S, Uchida-Kobayashi S, Takemura S, Tanaka S, Ohfuji S, Teranishi Y, Kozuka R, Kawamura E, Hagihara A, Morikawa H, Enomoto M, Murakami Y, Kawada N. Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication. PLoS One 2018;13:e0194163. [PMID: 29534101 DOI: 10.1371/journal.pone.0194163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
66 Pellicoro A, Aucott RL, Ramachandran P, Robson AJ, Fallowfield JA, Snowdon VK, Hartland SN, Vernon M, Duffield JS, Benyon RC, Forbes SJ, Iredale JP. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology. 2012;55:1965-1975. [PMID: 22223197 DOI: 10.1002/hep.25567] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 11.2] [Reference Citation Analysis]
67 Ding D, Chen LL, Zhai YZ, Hou CJ, Tao LL, Lu SH, Wu J, Liu XP. Trichostatin A inhibits the activation of Hepatic stellate cells by Increasing C/EBP-α Acetylation in vivo and in vitro. Sci Rep 2018;8:4395. [PMID: 29535398 DOI: 10.1038/s41598-018-22662-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
68 Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Büttner R, Schölmerich J, Hellerbrand C. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res. 2009;19:996-1005. [PMID: 19546889 DOI: 10.1038/cr.2009.73] [Cited by in Crossref: 130] [Cited by in F6Publishing: 126] [Article Influence: 10.8] [Reference Citation Analysis]
69 Gentilini A, Lottini B, Brogi M, Caligiuri A, Cosmi L, Marra F, Pinzani M. Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells. Fibrogenesis Tissue Repair 2009;2:1. [PMID: 19183465 DOI: 10.1186/1755-1536-2-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
70 Luo Z, Liu H, Sun X, Guo R, Cui R, Ma X, Yan M. RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats. PLoS One 2013;8:e55860. [PMID: 23409069 DOI: 10.1371/journal.pone.0055860] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
71 Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol. 2007;170:1807-1816. [PMID: 17525249 DOI: 10.2353/ajpath.2007.070112] [Cited by in Crossref: 1364] [Cited by in F6Publishing: 1237] [Article Influence: 97.4] [Reference Citation Analysis]
72 Lin YL, Lin CY, Chi CW, Huang YT. Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytother Res. 2009;23:927-932. [PMID: 19152370 DOI: 10.1002/ptr.2764] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
73 Ikeda H, Yatomi Y. Autotaxin in liver fibrosis. Clin Chim Acta. 2012;413:1817-1821. [PMID: 22820036 DOI: 10.1016/j.cca.2012.07.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
74 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1056/s0140-6736(08)60383-9] [Reference Citation Analysis]
75 Gonzalez SA, Fiel MI, Sauk J, Canchis PW, Liu RC, Chiriboga L, Yee HT, Jacobson IM, Talal AH. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J Viral Hepat 2009;16:141-8. [PMID: 19175868 DOI: 10.1111/j.1365-2893.2008.01052.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
76 Chakraborty JB, Oakley F, Walsh MJ. Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. Int J Hepatol. 2012;2012:648915. [PMID: 22567408 DOI: 10.1155/2012/648915] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 7.3] [Reference Citation Analysis]
77 Valera JM, Smok G, Márquez S, Poniachik J, Brahm J. [Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis]. Gastroenterol Hepatol. 2011;34:10-15. [PMID: 21194803 DOI: 10.1016/j.gastrohep.2010.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
78 Novosyadlyy R, Tron K, Dudas J, Ramadori G, Scharf J. Expression and regulation of the insulin-like growth factor axis components in rat liver myofibroblasts. J Cell Physiol 2004;199:388-98. [DOI: 10.1002/jcp.10437] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
79 Vallverdú J, Martínez García de la Torre RA, Mannaerts I, Verhulst S, Smout A, Coll M, Ariño S, Rubio-Tomás T, Aguilar-Bravo B, Martínez-Sánchez C, Blaya D, Verfaillie CM, van Grunsven LA, Sancho-Bru P. Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells. Nat Protoc 2021;16:2542-63. [PMID: 33864055 DOI: 10.1038/s41596-021-00509-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1111/j.1582-4934.2006.tb00292.x] [Cited by in Crossref: 512] [Cited by in F6Publishing: 495] [Article Influence: 34.1] [Reference Citation Analysis]
81 Starkel P, Leclercq IA. Animal models for the study of hepatic fibrosis. Best Pract Res Clin Gastroenterol. 2011;25:319-333. [PMID: 21497748 DOI: 10.1016/j.bpg.2011.02.004] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 10.4] [Reference Citation Analysis]
82 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
83 Hernández-Aquino E, Quezada-Ramírez MA, Silva-Olivares A, Casas-Grajales S, Ramos-Tovar E, Flores-Beltrán RE, Segovia J, Shibayama M, Muriel P. Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways. Eur J Pharmacol 2019;865:172730. [PMID: 31618621 DOI: 10.1016/j.ejphar.2019.172730] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
84 Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Omata M, Kimura S. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2003;285:G880-G886. [PMID: 12829436 DOI: 10.1152/ajpgi.00039.2003] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 2.7] [Reference Citation Analysis]
85 Leija Salas A, Ocampo G, Garrido Fariña G, Reyes-esparza J, Rodríguez-fragoso L. Genistein decreases liver fibrosis and cholestasis induced by prolonged biliary obstruction in the rat. Annals of Hepatology 2007;6:41-7. [DOI: 10.1016/s1665-2681(19)31952-0] [Cited by in Crossref: 14] [Article Influence: 1.0] [Reference Citation Analysis]
86 Zhang Y, Yao X. Suppressive effects of YiGanKang, a combination of Chinese herbs, on collagen synthesis in hepatic stellate cell. J Ethnopharmacol 2011;134:949-52. [PMID: 21333725 DOI: 10.1016/j.jep.2011.02.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
87 Ye Z, Houssein HS, Mahato RI. Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides 2007;17:349-404. [PMID: 18154454 DOI: 10.1089/oli.2007.0097] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
88 Murphy F, Arthur M, Iredale J. Developing strategies for liver fibrosis treatment. Expert Opin Investig Drugs 2002;11:1575-85. [PMID: 12437504 DOI: 10.1517/13543784.11.11.1575] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
89 Kitano M, Bloomston PM. Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis. J Clin Med. 2016;5. [PMID: 26999230 DOI: 10.3390/jcm5030038] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 12.4] [Reference Citation Analysis]
90 Priya S, Sudhakaran PR. Cell survival, activation and apoptosis of hepatic stellate cells: modulation by extracellular matrix proteins. Hepatol Res. 2008;38:1221-1232. [PMID: 18637147 DOI: 10.1111/j.1872-034x.2008.00394.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
91 Rachakonda V, Jadeja RN, Urrunaga NH, Shah N, Ahmad D, Cheng K, Twaddell WS, Raufman JP, Khurana S. M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice. Sci Rep 2015;5:14110. [PMID: 26374068 DOI: 10.1038/srep14110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
92 Delire B, Lebrun V, Selvais C, Henriet P, Bertrand A, Horsmans Y, Leclercq IA. Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling. Aging (Albany NY). 2016;9:98-113. [PMID: 27941216 DOI: 10.18632/aging.101124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
93 Friedman SL. Hepatic fibrosis-overview. Toxicology. 2008;254:120-129. [PMID: 18662740 DOI: 10.1016/j.tox.2008.06.013] [Cited by in Crossref: 240] [Cited by in F6Publishing: 214] [Article Influence: 18.5] [Reference Citation Analysis]
94 Li JT, Liao ZX, Ping J, Xu D, Wang H. Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol. 2008;43:419-428. [PMID: 18600385 DOI: 10.1007/s00535-008-2180-y] [Cited by in Crossref: 96] [Cited by in F6Publishing: 98] [Article Influence: 7.4] [Reference Citation Analysis]
95 Fallowfield JA, Kendall TJ, Iredale JP. Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis. 2006;10:481-497, viii. [PMID: 17162224 DOI: 10.1016/j.cld.2006.08.022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
96 Di Sario A, Bendia E, Svegliati Baroni G, Ridolfi F, Casini A, Ceni E, Saccomanno S, Marzioni M, Trozzi L, Sterpetti P, Taffetani S, Benedetti A. Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. J Hepatol 2002;37:584-91. [PMID: 12399223 DOI: 10.1016/s0168-8278(02)00245-3] [Cited by in Crossref: 86] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
97 Ji G, Wang L, Zhang SH, Liu JW, Zheng PY, Liu T. Effect of Chinese medicine Qinggan Huoxuefang on inducing HSC apoptosis in alcoholic liver fibrosis rats. World J Gastroenterol. 2006;12:2047-2052. [PMID: 16610055 DOI: 10.3748/wjg.v12.i13.2047] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
98 Tasci I, Mas MR, Vural SA, Comert B, Alcigir G, Serdar M, Mas N, Isik AT, Ates Y. Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery. Liver Int. 2006;26:261-268. [PMID: 16448466 DOI: 10.1111/j.1478-3231.2005.01210.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
99 Usher KM, Zhu S, Mavropalias G, Carrino JA, Zhao J, Xu J. Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Bone Res 2019;7:9. [PMID: 30937213 DOI: 10.1038/s41413-019-0047-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 15.5] [Reference Citation Analysis]
100 Zhou X, Murphy FR, Gehdu N, Zhang J, Iredale JP, Benyon RC. Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem. 2004;279:23996-24006. [PMID: 15044441 DOI: 10.1074/jbc.m311668200] [Cited by in Crossref: 150] [Cited by in F6Publishing: 80] [Article Influence: 8.8] [Reference Citation Analysis]
101 Kim HG, Wang JH, Han JM, Hwang SY, Lee DS, Son CG. Chunggan Extract (CGX), A Traditional Korean Herbal Medicine, Exerts Hepatoprotective Effects in a Rat Model of Chronic Alcohol Consumption: CGX HAS POTENT PROTECTIVE EFFECTS ON THE ALCOHOLIC LIVER INJURY. Phytother Res 2013;27:1854-62. [DOI: 10.1002/ptr.4935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
102 Manapov F, Muller P, Rychly J. Translocation of p21(Cip1/WAF1) from the nucleus to the cytoplasm correlates with pancreatic myofibroblast to fibroblast cell conversion. Gut 2005;54:814-22. [PMID: 15888791 DOI: 10.1136/gut.2003.036491] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
103 Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology. 2002;122:1525-1528. [PMID: 11984538 DOI: 10.1053/gast.2002.33367] [Cited by in Crossref: 163] [Cited by in F6Publishing: 156] [Article Influence: 8.6] [Reference Citation Analysis]
104 Staunton DE, Lupher ML, Liddington R, Gallatin WM. Targeting integrin structure and function in disease. Adv Immunol 2006;91:111-57. [PMID: 16938539 DOI: 10.1016/S0065-2776(06)91003-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
105 Pinzani M. Unraveling the spider web of hepatic stellate cell apoptosis. Gastroenterology 2009;136:2061-3. [PMID: 19416764 DOI: 10.1053/j.gastro.2009.04.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
106 Parajuli DR, Park EJ, Che XH, Jiang WY, Kim YC, Sohn DH, Lee SH. PF2401-SF, standardized fraction of Salvia miltiorrhiza, induces apoptosis of activated hepatic stellate cells in vitro and in vivo. Molecules 2013;18:2122-34. [PMID: 23389256 DOI: 10.3390/molecules18022122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
107 Taguchi S, Masumoto K, Yamanouchi T, Suita S. Decrease in hepatic circulation induces hepatic fibrosis in a neonatal piglet model with short bowel syndrome. J Pediatr Surg 2005;40:1592-7. [PMID: 16226990 DOI: 10.1016/j.jpedsurg.2005.06.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
108 Baligar P, Mukherjee S, Kochat V, Rastogi A, Mukhopadhyay A. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis. Stem Cells. 2015; Sep 21. [Epub ahead of print]. [PMID: 26389810 DOI: 10.1002/stem.2210] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
109 Janoschek N, van de Leur E, Gressner AM, Weiskirchen R. Induction of cell death in activated hepatic stellate cells by targeted gene expression of the thymidine kinase/ganciclovir system. Biochem Biophys Res Commun. 2004;316:1107-1115. [PMID: 15044099 DOI: 10.1016/j.bbrc.2004.02.147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
110 Shibata N, Watanabe T, Okitsu T, Sakaguchi M, Takesue M, Kunieda T, Omoto K, Yamamoto S, Tanaka N, Kobayashi N. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant. 2003;12:499-507. [PMID: 12953924 DOI: 10.3727/000000003108747064] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
111 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 64-85. [DOI: 10.1016/b978-1-4377-0881-3.00005-x] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
112 Matsuo M, Murata S, Hasegawa S, Hatada Y, Ohtsuka M, Taniguchi H. Novel liver fibrosis model in Macaca fascicularis induced by thioacetamide. Sci Rep 2020;10:2450. [PMID: 32051422 DOI: 10.1038/s41598-020-58739-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Liu Y, Wang Z, Wang J, Lam W, Kwong S, Li F, Friedman SL, Zhou S, Ren Q, Xu Z, Wang X, Ji L, Tang S, Zhang H, Lui EL, Ye T. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling. Liver Int 2013;33:504-15. [PMID: 23279742 DOI: 10.1111/liv.12034] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
114 Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Okudaira S, Tanaka M, Tomiya T. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol. 2007;41:616-623. [PMID: 17577119 DOI: 10.1097/01.mcg.0000225642.90898.0e] [Cited by in Crossref: 135] [Cited by in F6Publishing: 126] [Article Influence: 9.6] [Reference Citation Analysis]
115 Campana L, Iredale JP. Extracellular Matrix Metabolism and Fibrotic Disease. Curr Pathobiol Rep 2014;2:217-24. [DOI: 10.1007/s40139-014-0058-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
116 Lee JI, Lee KS, Paik YH, Nyun Park Y, Han KH, Chon CY, Moon YM. Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells. J Hepatol. 2003;39:960-966. [PMID: 14642612 DOI: 10.1016/s0168-8278(03)00411-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
117 Wang XZ, Chen ZX, Zhang LJ, Chen YX, Li D, Chen FL, Huang YH. Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosis. World J Gastroenterol. 2003;9:1287-1291. [PMID: 12800242 DOI: 10.3748/wjg.v9.i6.1287] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
118 Saile B, DiRocco P, Dudas J, El-Armouche H, Sebb H, Eisenbach C, Neubauer K, Ramadori G. IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). Lab Invest. 2004;84:1037-1049. [PMID: 15156158 DOI: 10.1038/labinvest.3700116] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
119 Zhang Z, Zha Y, Hu W, Huang Z, Gao Z, Zang Y, Chen J, Dong L, Zhang J. The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem. 2013;288:37082-37093. [PMID: 24196965 DOI: 10.1074/jbc.M113.517953] [Cited by in Crossref: 76] [Cited by in F6Publishing: 44] [Article Influence: 9.5] [Reference Citation Analysis]
120 Zhang LJ, Sun MY, Ning BB, Zhang WM, Chen GF, Mu YP, Zhang H, Liu J, Bian YQ, Liu P. Xiayuxue Decoction ([symbols; see text]) attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice. Chin J Integr Med. 2014;20:516-523. [PMID: 24972579 DOI: 10.1007/s11655-014-1862-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
121 Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta. 2013;1832:876-883. [PMID: 23149387 DOI: 10.1016/j.bbadis.2012.11.002] [Cited by in Crossref: 146] [Cited by in F6Publishing: 130] [Article Influence: 16.2] [Reference Citation Analysis]
122 Chor SY, Hui AY, To KF, Chan KK, Go YY, Chan HL, Leung WK, Sung JJ. Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. J Ethnopharmacol. 2005;100:180-186. [PMID: 15950418 DOI: 10.1016/j.jep.2005.02.036] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
123 Haldar D, Henderson NC, Hirschfield G, Newsome PN. Mesenchymal stromal cells and liver fibrosis: a complicated relationship. FASEB j 2016;30:3905-28. [DOI: 10.1096/fj.201600433r] [Cited by in Crossref: 46] [Cited by in F6Publishing: 22] [Article Influence: 9.2] [Reference Citation Analysis]
124 Jiang HQ, Zhang XL, Liu L, Yang CC. Relationship between focal adhesion kinase and hepatic stellate cell proliferation during rat hepatic fibrogenesis. World J Gastroenterol. 2004;10:3001-3005. [PMID: 15378782 DOI: 10.3748/wjg.v10.i20.3001] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
125 Petreaca M, Martins-green M. Cell-ECM Interactions in Repair and Regeneration. Principles of Regenerative Medicine. Elsevier; 2011. pp. 19-65. [DOI: 10.1016/b978-0-12-381422-7.10002-1] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
126 Sasaki R, Kanda T, Nakamura M, Nakamoto S, Haga Y, Wu S, Shirasawa H, Yokosuka O. Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells. PLoS One 2016;11:e0146314. [PMID: 26731332 DOI: 10.1371/journal.pone.0146314] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
127 Chen S, Jiang S, Zheng W, Tu B, Liu S, Ruan H, Fan C. RelA/p65 inhibition prevents tendon adhesion by modulating inflammation, cell proliferation, and apoptosis. Cell Death Dis 2017;8:e2710. [PMID: 28358376 DOI: 10.1038/cddis.2017.135] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
128 Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151-166. [PMID: 33128017 DOI: 10.1038/s41575-020-00372-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 31.0] [Reference Citation Analysis]
129 Zhao WX, Zhao J, Liang CL, Zhao B, Pang RQ, Pan XH. Effect of caffeic acid phenethyl ester on proliferation and apoptosis of hepatic stellate cells in vitro. World J Gastroenterol 2003;9:1278-81. [PMID: 12800240 DOI: 10.3748/wjg.v9.i6.1278] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
130 Tang X, Shu Z, Zhang W, Cheng L, Yu J, Zhang M, Zheng S. Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis. Ann Transl Med 2019;7:528. [PMID: 31807510 DOI: 10.21037/atm.2019.09.122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
131 Tsukamoto H, Zhu NL, Asahina K, Mann DA, Mann J. Epigenetic cell fate regulation of hepatic stellate cells. Hepatol Res. 2011;41:675-682. [PMID: 21504520 DOI: 10.1111/j.1872-034x.2011.00804.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
132 Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology. 2002;123:1323-1330. [PMID: 12360492 DOI: 10.1053/gast.2002.35953] [Cited by in Crossref: 222] [Cited by in F6Publishing: 204] [Article Influence: 11.7] [Reference Citation Analysis]
133 Kendall TJ, Hennedige S, Aucott RL, Hartland SN, Vernon MA, Benyon RC, Iredale JP. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatology. 2009;49:901-910. [PMID: 19072833 DOI: 10.1002/hep.22701] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
134 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1557] [Article Influence: 129.4] [Reference Citation Analysis]
135 Senoo H, Mezaki Y, Fujiwara M. The stellate cell system (vitamin A-storing cell system). Anat Sci Int. 2017;92:387-455. [PMID: 28299597 DOI: 10.1007/s12565-017-0395-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
136 Sun M, Kisseleva T. Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol. 2015;39:S60-S63. [PMID: 26206574 DOI: 10.1016/j.clinre.2015.06.015] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 15.2] [Reference Citation Analysis]
137 Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007;39:695-714. [PMID: 17110155 DOI: 10.1016/j.biocel.2006.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
138 Popov Y, Sverdlov DY, Bhaskar KR, Sharma AK, Millonig G, Patsenker E, Krahenbuhl S, Krahenbuhl L, Schuppan D. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G323-G334. [PMID: 20056896 DOI: 10.1152/ajpgi.00394.2009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 8.1] [Reference Citation Analysis]
139 Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Watanabe N, Kitamura K, Isono T, Yahagi N, Noiri E, Inao M, Mochida S, Kume Y, Yatomi Y, Nakahara K, Omata M, Fujiwara K. The herbal medicine inchin-ko-to (TJ-135) induces apoptosis in cultured rat hepatic stellate cells. Life Sciences 2006;78:2226-33. [DOI: 10.1016/j.lfs.2005.09.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
140 Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res. 2008;25:249-258. [PMID: 17577645 DOI: 10.1007/s11095-007-9311-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
141 Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38-S53. [PMID: 12591185 DOI: 10.1016/s0168-8278(02)00429-4] [Cited by in Crossref: 1077] [Cited by in F6Publishing: 434] [Article Influence: 59.8] [Reference Citation Analysis]
142 Aprigliano I, Dudas J, Ramadori G, Saile B. Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells. Liver Int 2008;28:546-57. [PMID: 18339080 DOI: 10.1111/j.1478-3231.2008.01682.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
143 Kissin E, Korn JH. Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis. Curr Rheumatol Rep 2002;4:129-35. [PMID: 11890878 DOI: 10.1007/s11926-002-0008-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
144 Lin Y, Lee T, Huang Y, Huang Y. Inhibitory effects of Ligusticum chuanxiong on the proliferation of rat hepatic stellate cells. J Gastroenterol Hepatol 2006;21:1257-65. [DOI: 10.1111/j.1440-1746.2006.04326.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
145 Yoshino K, Taura K, Iwaisako K, Masano Y, Uemoto Y, Kimura Y, Nam NH, Nishino H, Ikeno Y, Okuda Y, Nishio T, Yamamoto G, Seo S, Uemoto S. Novel mouse model for cholestasis-induced liver fibrosis resolution by cholecystojejunostomy. J Gastroenterol Hepatol 2021. [PMID: 33448457 DOI: 10.1111/jgh.15406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol. 2002;160:1705-1715. [PMID: 12000722 DOI: 10.1016/s0002-9440(10)61117-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
147 Orr JG, Leel V, Cameron GA, Marek CJ, Haughton EL, Elrick LJ, Trim JE, Hawksworth GM, Halestrap AP, Wright MC. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 2004;40:232-242. [PMID: 15239107 DOI: 10.1002/hep.20254] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
148 Issa R, Zhou X, Trim N, Millward-Sadler H, Krane S, Benyon C, Iredale J. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J. 2003;17:47-49. [PMID: 12475903 DOI: 10.1096/fj.02-0494fje] [Cited by in Crossref: 147] [Cited by in F6Publishing: 132] [Article Influence: 7.7] [Reference Citation Analysis]
149 El Agha E, Moiseenko A, Kheirollahi V, De Langhe S, Crnkovic S, Kwapiszewska G, Szibor M, Kosanovic D, Schwind F, Schermuly RT, Henneke I, MacKenzie B, Quantius J, Herold S, Ntokou A, Ahlbrecht K, Braun T, Morty RE, Günther A, Seeger W, Bellusci S. Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. Cell Stem Cell 2017;20:261-273.e3. [PMID: 27867035 DOI: 10.1016/j.stem.2016.10.004] [Cited by in Crossref: 103] [Cited by in F6Publishing: 83] [Article Influence: 20.6] [Reference Citation Analysis]
150 Thuy LTT, Hai H, Kawada N. Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis. Clin Mol Hepatol 2020;26:280-93. [PMID: 32492766 DOI: 10.3350/cmh.2020.0037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
151 Malekzadeh R, Mohamadnejad M, Rakhshani N, Nasseri-Moghaddam S, Merat S, Tavangar SM, Sohrabpour AA. Reversibility of cirrhosis in chronic hepatitis B. Clin Gastroenterol Hepatol. 2004;2:344-347. [PMID: 15067631 DOI: 10.1016/s1542-3565(04)00066-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
152 Ramadori G, Saile B. Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology. 2004;127:997-1000. [PMID: 15362057 DOI: 10.1053/j.gastro.2004.07.041] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.0] [Reference Citation Analysis]
153 Hasegawa D, Wallace MC, Friedman SL. Stellate Cells and Hepatic Fibrosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 41-62. [DOI: 10.1016/b978-0-12-800134-9.00004-x] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
154 Zhang Y, Ai X, Zhang J, Yao X. Differential role of YiGanKang Decoction in IL-1β induction of IL-1RI and AP-1 in rat hepatic stellate cell. Journal of Ethnopharmacology 2012;141:599-602. [DOI: 10.1016/j.jep.2011.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
155 Oakley F, Teoh V, Ching-A-Sue G, Bataller R, Colmenero J, Jonsson JR, Eliopoulos AG, Watson MR, Manas D, Mann DA. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 2009;136:2334-2344.e1. [PMID: 19303015 DOI: 10.1053/j.gastro.2009.02.081] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
156 Potter JJ, Liu X, Koteish A, Mezey E. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int. 2013;33:677-686. [PMID: 23413886 DOI: 10.1111/liv.12122] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
157 Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol. 2004;40:646-652. [PMID: 15030981 DOI: 10.1016/j.jhep.2004.01.009] [Cited by in Crossref: 164] [Cited by in F6Publishing: 130] [Article Influence: 9.6] [Reference Citation Analysis]
158 Snowdon VK, Fallowfield JA. Models and mechanisms of fibrosis resolution. Alcohol Clin Exp Res. 2011;35:794-799. [PMID: 21284668 DOI: 10.1111/j.1530-0277.2010.01400.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
159 Lin YL, Lee TF, Huang YJ, Huang YT. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells. J Pharm Pharmacol. 2006;58:933-939. [PMID: 16805953 DOI: 10.1211/jpp.58.7.0008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
160 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1111/J.1528-4934.2006.th00292.x] [Reference Citation Analysis]
161 Scriabine A, Rabin DU. New Developments in the Therapy of Pulmonary Fibrosis. Contemporary Aspects of Biomedical Research - Drug Discovery. Elsevier; 2009. pp. 419-64. [DOI: 10.1016/s1054-3589(08)57011-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
162 Lamireau T, Desmoulière A, Bioulac-Sage P, Rosenbaum J. Mechanisms of hepatic fibrogenesis. Arch Pediatr. 2002;9:392-405. [PMID: 11998427 DOI: 10.1016/s0929-693x(01)00800-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
163 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 322] [Article Influence: 49.6] [Reference Citation Analysis]
164 Aloman C, Friedman SL, Merad M. Dendritic cells in alcoholic liver injury and fibrosis. Alcohol Clin Exp Res 2011;35:776-81. [PMID: 21284665 DOI: 10.1111/j.1530-0277.2010.01397.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
165 Fallowfield JA, Iredale JP. Targeted treatments for cirrhosis. Expert Opin Ther Targets. 2004;8:423-435. [PMID: 15469393 DOI: 10.1517/14728222.8.5.423] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
166 Schuppan D, Popov Y. Rationale and targets for antifibrotic therapies. Gastroenterol Clin Biol 2009;33:949-57. [PMID: 19726145 DOI: 10.1016/j.gcb.2009.07.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
167 Liu Y, Meyer C, Xu C, Weng H, Hellerbrand C, ten Dijke P, Dooley S. Animal models of chronic liver diseases. Am J Physiol Gastrointest Liver Physiol. 2013;304:G449-G468. [PMID: 23275613 DOI: 10.1152/ajpgi.00199.2012] [Cited by in Crossref: 118] [Cited by in F6Publishing: 101] [Article Influence: 13.1] [Reference Citation Analysis]
168 Fujimoto J, Iimuro Y. Carbon Tetrachloride-Induced Hepatotoxicity*. Comprehensive Toxicology. Elsevier; 2010. pp. 437-55. [DOI: 10.1016/b978-0-08-046884-6.01018-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
169 Sánchez-Muñoz D, Castellano-Megías VM, Romero-Gómez M. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis. Dig Liver Dis 2007;39:262-6. [PMID: 17270507 DOI: 10.1016/j.dld.2006.12.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
170 Morii M, Mezaki Y, Yamaguchi N, Yoshikawa K, Miura M, Imai K, Yoshino H, Hebiguchi T, Hebiguchi T, Senoo H. Onset of Apoptosis in the Cystic Duct During Metamorphosis of a Japanese Lamprey, Lethenteron reissneri. Anat Rec 2010;293:1155-66. [DOI: 10.1002/ar.21151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
171 Liu X, Xu J, Brenner DA, Kisseleva T. Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts. Curr Pathobiol Rep. 2013;1:209-214. [PMID: 24000319 DOI: 10.1007/s40139-013-0018-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
172 Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, Safadi R, Lee SS, Halota W, Goodman Z, Chi YC, Zhang H, Hindes R, Iloeje U, Beebe S, Kreter B. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52:886-893. [PMID: 20683932 DOI: 10.1002/hep.23785] [Cited by in Crossref: 627] [Cited by in F6Publishing: 569] [Article Influence: 57.0] [Reference Citation Analysis]
173 Zhang Y, Ikegami T, Honda A, Miyazaki T, Bouscarel B, Rojkind M, Hyodo I, Matsuzaki Y. Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology. 2006;44:612-622. [PMID: 16941698 DOI: 10.1002/hep.21315] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
174 D'Ambrosio R, Aghemo A, Rumi MG, Ronchi G, Donato MF, Paradis V, Colombo M, Bedossa P. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis. Hepatology. 2012;56:532-543. [PMID: 22271347 DOI: 10.1002/hep.25606] [Cited by in Crossref: 261] [Cited by in F6Publishing: 232] [Article Influence: 29.0] [Reference Citation Analysis]
175 Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, de Oliveira CP, Andraus W, Alves VA, Leclercq I. Experimental models of liver fibrosis. Arch Toxicol. 2016;90:1025-1048. [PMID: 26047667 DOI: 10.1007/s00204-015-1543-4] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 18.0] [Reference Citation Analysis]
176 Nakamuta M, Kotoh K, Enjoji M, Nawata H. Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE. World J Gastroenterol. 2005;11:2264-2268. [PMID: 15818737 DOI: 10.3748/wjg.v11.i15.2264] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
177 Scharf JG, Dombrowski F, Novosyadlyy R, Eisenbach C, Demori I, Kubler B, Braulke T. Insulin-like growth factor (IGF)-binding protein-1 is highly induced during acute carbon tetrachloride liver injury and potentiates the IGF-I-stimulated activation of rat hepatic stellate cells. Endocrinology. 2004;145:3463-3472. [PMID: 15070850 DOI: 10.1210/en.2003-1541] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
178 Weston CJ, Zimmermann HW, Adams DH. The Role of Myeloid-Derived Cells in the Progression of Liver Disease. Front Immunol 2019;10:893. [PMID: 31068952 DOI: 10.3389/fimmu.2019.00893] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
179 Estep JM, O'Reilly L, Grant G, Piper J, Jonsson J, Afendy A, Chandhoke V, Younossi ZM. Hepatic stellate cell and myofibroblast-like cell gene expression in the explanted cirrhotic livers of patients undergoing liver transplantation. Dig Dis Sci 2010;55:496-504. [PMID: 19680808 DOI: 10.1007/s10620-009-0919-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
180 Anthony BJ, Ramm GA, McManus DP. Role of resident liver cells in the pathogenesis of schistosomiasis. Trends Parasitol 2012;28:572-9. [PMID: 23099112 DOI: 10.1016/j.pt.2012.09.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
181 Hayashi S, Itoh A, Isoda K, Kondoh M, Kawase M, Yagi K. Fucoidan partly prevents CCl4-induced liver fibrosis. Eur J Pharmacol 2008;580:380-4. [PMID: 18068155 DOI: 10.1016/j.ejphar.2007.11.015] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
182 Tu T, Calabro SR, Lee A, Maczurek AE, Budzinska MA, Warner FJ, McLennan SV, Shackel NA. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis? J Gastroenterol Hepatol. 2015;30:1696-1704. [PMID: 26239824 DOI: 10.1111/jgh.13065] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
183 Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther. 2004;308:1191-1196. [PMID: 14617689 DOI: 10.1124/jpet.103.060129] [Cited by in Crossref: 158] [Cited by in F6Publishing: 145] [Article Influence: 8.8] [Reference Citation Analysis]
184 Chen Q, Chen L, Wu X, Zhang F, Jin H, Lu C, Shao J, Kong D, Wu L, Zheng S. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway: DHA Prevents Hepatic Fibrosis by Inducing HSC Apoptosis. IUBMB Life 2016;68:220-31. [DOI: 10.1002/iub.1478] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
185 Pinzani M, Vizzutti F. Fibrosis and cirrhosis reversibility: clinical features and implications. Clin Liver Dis. 2008;12:901-913, x. [PMID: 18984473 DOI: 10.1016/j.cld.2008.07.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
186 Nabil A, Uto K, Zahran F, Soliman R, Hassan AA, Elshemy MM, Ali IS, Ebara M, Shiha G. The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs. Biomed Res Int 2021;2021:6678913. [PMID: 33855079 DOI: 10.1155/2021/6678913] [Reference Citation Analysis]
187 Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007;117:539-548. [PMID: 17332881 DOI: 10.1172/jci30542] [Cited by in Crossref: 552] [Cited by in F6Publishing: 287] [Article Influence: 39.4] [Reference Citation Analysis]
188 Tang X, Yang J, Li J. Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis. Life Sciences 2009;84:552-7. [DOI: 10.1016/j.lfs.2009.01.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
189 Ping J, Gao AM, Qin HQ, Wei XN, Bai J, Liu L, Li XH, Li RW, Ao Y, Wang H. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway. J Pharmacol Exp Ther. 2011;339:694-703. [PMID: 21862660 DOI: 10.1124/jpet.111.179820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
190 Yeh YH, Liang CY, Chen ML, Tsai FM, Lin YY, Lee MC, Wu JS, Kuo CY. Apoptotic effects of hsian-tsao (Mesona procumbens Hemsley) on hepatic stellate cells mediated by reactive oxygen species and ERK, JNK, and caspase-3 pathways. Food Sci Nutr 2019;7:1891-8. [PMID: 31139404 DOI: 10.1002/fsn3.1046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
191 Demetris AJ, Bellamy CO, Gandhi CR, Prost S, Nakanuma Y, Stolz DB. Functional Immune Anatomy of the Liver-As an Allograft. Am J Transplant. 2016;16:1653-1680. [PMID: 26848550 DOI: 10.1111/ajt.13749] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
192 Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181-194. [PMID: 24566915 DOI: 10.1038/nri3623] [Cited by in Crossref: 652] [Cited by in F6Publishing: 605] [Article Influence: 93.1] [Reference Citation Analysis]
193 Wang XZ, Zhang SJ, Chen YX, Chen ZX, Huang YH, Zhang LJ. Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro. World J Gastroenterol. 2004;10:2706-2710. [PMID: 15309723 DOI: 10.3748/wjg.v10.i18.2706] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
194 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 87-109. [DOI: 10.1016/b978-1-4160-3258-8.50011-5] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
195 Kemp R, de Araújo WM, de Castro AA, Ardengh JC, Neder L, dos Santos JS. Influence of Biliary Drainage on the Repair of Hepatic Lesions in Biliary Fibrosis. Journal of Surgical Research 2011;169:e127-36. [DOI: 10.1016/j.jss.2011.04.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
196 Shaker ME, Ghani A, Shiha GE, Ibrahim TM, Mehal WZ. Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases. Biochim Biophys Acta. 2013;1833:1992-2003. [PMID: 23499874 DOI: 10.1016/j.bbamcr.2013.02.033] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
197 Omar R, Yang J, Liu H, Davies NM, Gong Y. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Rev Physiol Biochem Pharmacol 2016;172:1-37. [PMID: 27534415 DOI: 10.1007/112_2016_6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
198 Patsenker E, Popov Y, Wiesner M, Goodman SL, Schuppan D. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J Hepatol 2007;46:878-87. [PMID: 17258347 DOI: 10.1016/j.jhep.2006.11.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
199 Hodge A, Lourensz D, Vaghjiani V, Nguyen H, Tchongue J, Wang B, Murthi P, Sievert W, Manuelpillai U. Soluble factors derived from human amniotic epithelial cells suppress collagen production in human hepatic stellate cells. Cytotherapy 2014;16:1132-44. [PMID: 24642017 DOI: 10.1016/j.jcyt.2014.01.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
200 Agarwal K, Czaja AJ, Donaldson PT. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens. 2007;69:227-235. [PMID: 17493146 DOI: 10.1111/j.1399-0039.2006.00794.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
201 Kisseleva T, Brenner DA. Anti-fibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol. 2011;25:305-317. [PMID: 21497747 DOI: 10.1016/j.bpg.2011.02.011] [Cited by in Crossref: 116] [Cited by in F6Publishing: 115] [Article Influence: 11.6] [Reference Citation Analysis]
202 Kendall TJ, Dolman GE, Duff CM, Paish EC, Zaitoun A, Irving W, Fallowfield JA, Guha IN. Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease. Histopathology 2018;73:90-100. [PMID: 29464815 DOI: 10.1111/his.13499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
203 Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem. 2002;277:11069-11076. [PMID: 11796725 DOI: 10.1074/jbc.m111490200] [Cited by in Crossref: 310] [Cited by in F6Publishing: 132] [Article Influence: 16.3] [Reference Citation Analysis]
204 Lotersztajn S, Mallat A. Hepatic Stellate Cells as Target for Reversal of Fibrosis/Cirrhosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 175-84. [DOI: 10.1016/b978-0-12-800134-9.00011-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
205 Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, Petrai I, Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M, Parola M. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006;55:1174-82. [PMID: 16423888 DOI: 10.1136/gut.2005.082701] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 7.7] [Reference Citation Analysis]
206 Osawa Y, Oboki K, Imamura J, Kojika E, Hayashi Y, Hishima T, Saibara T, Shibasaki F, Kohara M, Kimura K. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice. EBioMedicine. 2015;2:1751-1758. [PMID: 26870800 DOI: 10.1016/j.ebiom.2015.10.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
207 Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol. 2010;1:69-84. [PMID: 21607144 DOI: 10.4291/wjgp.v1.i2.69] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
208 Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility - molecular mechanisms. Clin Liver Dis. 2008;12:915-937, xi. [PMID: 18984474 DOI: 10.1016/j.cld.2008.07.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
209 Feldmann G. L’apoptose hépatique. Gastroentérologie Clinique et Biologique 2006;30:533-45. [DOI: 10.1016/s0399-8320(06)73222-5] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]